Stocklytics Platform
Asset logo for symbol AMGN
Amgen
AMGN72
$264.49arrow_drop_up0.16%$0.42
S&P500
Asset logo for symbol AMGN
AMGN72

$264.49

arrow_drop_up0.16%
Key Stats
Open$262.48
Prev. Close$264.00
EPS7.82
Next Earnings DateJun 3, 2025
LOWHIGH
Day Range261.49
264.49
52 Week Range249.70
346.85
Ratios
EPS7.82
Fundamentals
Industry average yield2.90%
Last Dividend pay dateMar 7, 2025

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

AMGN-
US Healthcare Sector-
US Market-
warning

AMGN / Market

AMGN lose to the US Market which returned 1.00% over the last twenty four hours.
warning

AMGN / Healthcare Sector

AMGN lose to the US Healthcare sector which returned 2.95% over the last twenty four hours.

Amgen (AMGN) Statistics

Amgen Inc, also known as AMGN, is a biotechnology company that specializes in developing and manufacturing human therapeutics. As of the latest valuation metrics, AMGN has a market capitalization of around $139 billion. The company's valuation is determined by various factors such as its revenue growth, profitability, and overall financial health. When analyzing the fundamentals of Amgen Inc, it is essential to consider key metrics such as its revenue per share, enterprise to EBITDA ratio, profit margin, total debt, and gross profit. These metrics provide insights into the company's financial performance and stability.
In terms of stock performance compared to its sector, AMGN has shown resilience and strong growth. Despite facing industry challenges, Amgen Inc has managed to outperform its peers and deliver solid returns to investors. The company's dedication to research and development, as well as its robust product portfolio, have contributed to its success in the market. When examining the revenue per share, Amgen Inc has consistently demonstrated its ability to generate substantial revenue. This indicates that the company has a strong customer base and demand for its products.
add Amgen  to watchlist

Keep an eye on Amgen

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the EBITDA of Amgen (AMGN) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Amgen (AMGN) is $13.48B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Amgen (AMGN) have?

Amgen (AMGN) has a total debt of $60.4B. The net debt, which accounts for cash and cash equivalents against the total debt, is $51.39B.
help

How has Amgen (AMGN) stock's performance compared to its sector and the market over the past year?

Over the past year, Amgen (AMGN) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 25.34%, Amgen has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 47.67%, it has fallen short of the market average. This comparison highlights Amgen 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Amgen (AMGN) stock?

The PE (Price to Earnings) ratio of Amgen (AMGN) is currently 33.82. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of Amgen (AMGN) stock?

The Earnings Per Share (EPS) for Amgen (AMGN), calculated on a diluted basis, is $7.82. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Amgen (AMGN) stock?

The operating margin for Amgen (AMGN) is 24.16%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.

Take Your Investments to a Whole New Level